|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Human SerpinA3 ORF mammalian expression plasmid, C-GFPSpark tag||HG10307-ACG|
|Human SerpinA3 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||HG10307-ACR|
|Human SerpinA3 ORF mammalian expression plasmid, C-Flag tag||HG10307-CF|
|Human SerpinA3 ORF mammalian expression plasmid, C-His tag||HG10307-CH|
|Human SerpinA3 ORF mammalian expression plasmid, C-Myc tag||HG10307-CM|
|Human SerpinA3 ORF mammalian expression plasmid, C-HA tag||HG10307-CY|
|Human SerpinA3 Gene cDNA clone plasmid||HG10307-M|
|Human SerpinA3 ORF mammalian expression plasmid, N-Flag tag||HG10307-NF|
|Human SerpinA3 ORF mammalian expression plasmid, N-His tag||HG10307-NH|
|Human SerpinA3 ORF mammalian expression plasmid, N-Myc tag||HG10307-NM|
|Human SerpinA3 ORF mammalian expression plasmid, N-HA tag||HG10307-NY|
|Human SerpinA3 natural ORF mammalian expression plasmid||HG10307-UT|
|Learn more about expression Vectors|
Human SerpinA3, also known as Alpha 1-antichymotrypsin (AACT), is a plasma alpha globulin glycoprotein, and is a member of serpin superfamily of the serine protease inhibitors consisting of at least 35 members. SerpinA3 has been demonstrated to inhibit the activity of certain serine proteases, such as cathepsin G found in neutrophils, and chymases present in mast cells, by inducing a major conformational rearrangement, and thus protects some tissues from damage caused by proteolytic enzymes. This enzyme is produced primarily in the liver, and is identified as an acute-phase inflammatory protein. SerpinA3 deficiency has been associated with liver disease, and mutations of this gene have been observed in patients with Parkinson disease and chronic obstructive pulmonary disease. In addition, ACT gene polymorphism has been implicated with Alzheimer’s disease (AD), cerebral amyloid angiopathy (CAA), as well as stroke, since SerpinA3 is a major constituent of the plaques in AD and an inhibitor of amyloid beta peptide degradation.